MA50212A - Procédé de préparation et de stockage prolongé de facteurs de croissance et de cytokines obtenus à partir d'un plasma riche en plaquettes - Google Patents

Procédé de préparation et de stockage prolongé de facteurs de croissance et de cytokines obtenus à partir d'un plasma riche en plaquettes

Info

Publication number
MA50212A
MA50212A MA050212A MA50212A MA50212A MA 50212 A MA50212 A MA 50212A MA 050212 A MA050212 A MA 050212A MA 50212 A MA50212 A MA 50212A MA 50212 A MA50212 A MA 50212A
Authority
MA
Morocco
Prior art keywords
platelets
preparation
growth factors
prolonged storage
plasma rich
Prior art date
Application number
MA050212A
Other languages
English (en)
Inventor
Irina Brokhman
Anthony Galea
Original Assignee
Antnor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antnor Ltd filed Critical Antnor Ltd
Publication of MA50212A publication Critical patent/MA50212A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA050212A 2016-12-06 2017-12-06 Procédé de préparation et de stockage prolongé de facteurs de croissance et de cytokines obtenus à partir d'un plasma riche en plaquettes MA50212A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2950659A CA2950659A1 (fr) 2016-12-06 2016-12-06 Methode de preparation et de rangement prolonge de facteurs de croissance et de cytokines obtenus de plasma riche en plaquettes

Publications (1)

Publication Number Publication Date
MA50212A true MA50212A (fr) 2020-07-22

Family

ID=62488789

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050212A MA50212A (fr) 2016-12-06 2017-12-06 Procédé de préparation et de stockage prolongé de facteurs de croissance et de cytokines obtenus à partir d'un plasma riche en plaquettes

Country Status (10)

Country Link
US (1) US20190343878A1 (fr)
EP (1) EP3551215A4 (fr)
JP (1) JP2020500933A (fr)
AU (1) AU2017372895A1 (fr)
CA (2) CA2950659A1 (fr)
GB (1) GB2574333A (fr)
IL (1) IL266542A (fr)
MA (1) MA50212A (fr)
MX (1) MX2019006549A (fr)
WO (1) WO2018102909A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020243808A1 (fr) * 2019-06-05 2020-12-10 Antnor Limited Procédé de préparation et de stockage prolongé de facteurs de croissance et de cytokines obtenus à partir d'un plasma riche en plaquettes
WO2020243807A1 (fr) * 2019-06-05 2020-12-10 Antnor Limited Méthode et composition pour produire des agents régénérateurs et anti-inflammatoires/anti-cataboliques améliorés à partir d'un liquide physiologique autologue
TR201910227A2 (tr) * 2019-07-09 2019-07-22 Gazi Enduestri Anonim Sirketi Bi̇r dolgu malzemesi̇ olarak kati plazma elde etme yöntemi̇
CN111110915A (zh) * 2020-02-28 2020-05-08 珠海中信大有科技有限公司 用于构建肌骨组织的自体生长因子补片的制作方法及应用
CA3076046A1 (fr) * 2020-03-17 2021-09-17 Antnor Limited Methode de production d`agents anti-inflammatoires/anticataboliques a partir d`un fluide physiologique autologue comportant une duree d`incubation reduite

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2369945B1 (es) * 2011-07-29 2012-10-15 Eduardo Anitua Aldecoa Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento.
US20140271589A1 (en) * 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
ES2883580T3 (es) * 2013-03-21 2021-12-09 Collplant Ltd Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
CA2866480A1 (fr) * 2014-09-30 2016-03-30 Antnor Limited Methode et composition destinees a la production d'agents anti-inflammatoires et regeneratifs ameliores a partir de liquides physiologiques autologues

Also Published As

Publication number Publication date
WO2018102909A1 (fr) 2018-06-14
CA2950659A1 (fr) 2018-06-06
GB201908795D0 (en) 2019-07-31
MX2019006549A (es) 2019-08-16
GB2574333A (en) 2019-12-04
JP2020500933A (ja) 2020-01-16
US20190343878A1 (en) 2019-11-14
EP3551215A4 (fr) 2020-07-22
IL266542A (en) 2019-07-31
CA3043939A1 (fr) 2018-06-14
EP3551215A1 (fr) 2019-10-16
AU2017372895A1 (en) 2019-05-30

Similar Documents

Publication Publication Date Title
MA50212A (fr) Procédé de préparation et de stockage prolongé de facteurs de croissance et de cytokines obtenus à partir d'un plasma riche en plaquettes
MA46479A (fr) Procédés et intermédiaires pour la préparation de nouveaux composés substitués de 6,7-dihydro-5h-benzo[7]annulène
MA46240A (fr) Compositions d'arn de haute pureté et procédés pour leur préparation
MA52665A (fr) Procédé d'amélioration de l'expression de l'hémoglobine foetale
MA43242A (fr) Mélange pour traiter des engrais à base d'urée
DK3615057T3 (da) Doseringsskema til behandling af kognitive svækkelser med blodplasmaprodukter
MA53920A (fr) Procédé de fourniture d'administration sous-cutanée d'anticorps anti-cd38
MA41200A (fr) Procédé pour la préparation d'un composé diarylthiohydantoïne
MA51988A (fr) Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale
MA43835A (fr) Procédé de préparation de lieurs de médicaments pégylés et leurs intermédiaires
MA49291A (fr) Procédé de fabrication d'oxyde de graphène réduit à partir de graphite de sursaturation
MA50169A (fr) Procédé de production d'un électrocatalyseur
EA201691600A1 (ru) Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений
MA45183A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA49775A (fr) Procédés de préparation d'oligomères morpholino de phosphorodiamidate
MA49272A (fr) Procédé de fabrication d'oxyde de graphène à partir de graphite primaire
PH12018501161A1 (en) Pharmaceutical composition containing 2-{4-[n-(5,6- diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n- (methylsulfonyl)acetamide
MA42423A (fr) Procédé de préparation d'un revêtement
ITUA20161408A1 (it) Macchina e procedimento per la preparazione di medicamenti intravenosi
MA53370A (fr) Procédé et intermédiaires pour la préparation de bilastine
MA43825A (fr) Schémas posologiques pour le traitement d'infections fongiques
MA55917A (fr) Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie
MA45768A (fr) Procédé pour la préparation de compositions d'immunoglobulines
EP3497077A4 (fr) Composés amides, compositions pharmaceutiques les contenant et leurs procédés d'utilisation
MA50124A (fr) Procédé de préparation de tubulysines et d'intermédiaires de celles-ci